{"id":537004,"date":"2021-09-10T12:03:17","date_gmt":"2021-09-10T16:03:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/"},"modified":"2021-09-10T12:03:17","modified_gmt":"2021-09-10T16:03:17","slug":"u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/","title":{"rendered":"U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing"},"content":{"rendered":"
\n

Group focused on employees’ safe return to offices sees requirement as driving individual health and wellness and workplace safety<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, Sept. 10, 2021<\/span> \/PRNewswire\/ —\u00a0The U.S. Rapid Action Consortium commends U.S. President Joe Biden’s<\/span> call for companies with more than 100 employees to require vaccinations or weekly tests to ensure individual health and workplace safety. The Consortium also supports expanding easy-to-use testing production and making at-home tests more affordable.<\/p>\n

The organization, which has been focused on reopening the U.S. economy quickly since its inception in March 2021<\/span>, is helping companies accelerate the use of safe, cost-effective rapid COVID-19 testing to better enable businesses to return to the office safely.<\/p>\n

Built on the highly successful Canadian model, the U.S. expansion is led by the Creative Destruction Lab Rapid Screening Consortium (CDL RSC)<\/a>, Genpact (NYSE: G)<\/a> and the COVID Collaborative<\/a>.<\/p>\n

“President Biden’s call for employers to do their part is a critical step in our collective fight against COVID-19,” said Darren Saumur<\/span>, global operating officer, Genpact and Advisory Committee Member of the U.S. Rapid Action Consortium<\/b>. “Experts agree that COVID-19 will not be eradicated anytime soon, and rapid antigen testing, along with other actions, are essential to public and workplace safety. Testing and vaccinations are two critical elements of an effective reopening strategy that go hand in hand.”<\/p>\n

Founded on the belief that the private sector is and must be a powerful part of the overall solution to end the pandemic, the Consortium brings together leading academics, scientists, organizations, and businesses to accelerate the fight against COVID-19. The group is offering all learnings and approaches free of charge as a public good to organizations, large and small.<\/p>\n

The U.S. Rapid Action Consortium is an expansion of the successful CDL RSC work done in Canada<\/span>. The Consortium is leveraging thousands of hours of research, vast quantities of data, and insights from thousands of rapid tests conducted in more than 900 workplace testing sites across Canada<\/span>.<\/p>\n

“The CDL Rapid Screening Consortium has scaled from coast to coast in Canada<\/span>. The program provides support, training, and an easy-to-use data reporting system to businesses of two employees to 200,000 employees.\u00a0Since June 2021<\/span>, our program uptake has increased by 500% and number of individuals regularly screened has grown by 200%,” said Sonia Sennik<\/span>, executive director, Creative Destruction Lab Rapid Screening Consortium and Advisory Committee Member of the U.S. Rapid Action Consortium.<\/b><\/p>\n

Since their inception, the Rapid Action Consortium and CDL RSC have administered more than 630,000 tests across more than 900 locations.\u00a0Results detected over 500 asymptomatic individuals, preventing more than 22,000 secondary infections from occurring.<\/p>\n

Companies interested in learning more about the U.S. Rapid Action Consortium may visit its website here<\/a>.<\/p>\n

\n About Genpact<\/b>
\n
Genpact (NYSE: G) is a global professional services firm that makes business transformation real. Led by our purpose — the relentless pursuit of a world that works better for people — we drive digital-led innovation and digitally enabled intelligent operations for our clients. Guided by our experience reinventing and running thousands of processes for hundreds of clients, many of them Global Fortune 500 companies, we drive real-world transformation at scale. We think with design, dream in digital, and solve problems with data and analytics. Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details \u2013 all 90,000+ of us. From New York<\/span> to New Delhi<\/span>, and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent the ways companies work. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we’ll be there with you \u2013 accelerating digital transformation to create bold, lasting results \u2013because\u00a0transformation happens here<\/a>. Get to know us at\u00a0Genpact.com<\/a>\u00a0and on\u00a0LinkedIn<\/a>,\u00a0Twitter<\/a>,\u00a0YouTube<\/a>, and\u00a0Facebook<\/a>.<\/p>\n

\n About the COVID Collaborative<\/b>
\n
COVID Collaborative, a project of UNITE, is a national assembly of experts, leaders and institutions in health, education and the economy and associations representing the diversity of the country to turn the tide on the pandemic by supporting federal, state and local COVID-19 response efforts.<\/p>\n

The COVID Collaborative is co-chaired by former Governor and U.S. Senator Dirk Kempthorne<\/span> (R-ID) and former Governor Deval Patrick<\/span> (D-MA) and led by CEO John Bridgeland<\/span>. COVID Collaborative includes expertise from across Republican and Democratic administrations at the federal, state and local levels, including former FDA commissioners, CDC directors, and U.S. surgeon generals; former U.S. secretaries of Education, Homeland Security and Health and Human Services; leading public health experts and institutions that span the country; the Business Roundtable, National Association of Manufacturers and U.S. Chamber of Commerce; the NAACP, UnidosUS and the National Congress of American Indians; the Skoll Foundation, The Allstate Foundation and The Rockefeller Foundation; and associations representing those on the front lines, from the American Public Health Association and Association of State and Territorial Health Officials to the Council of Chief State School Officers and the Council of the Great City Schools. Tim Shriver<\/span> is Chairman of UNITE.<\/p>\n

To learn more, visit\u00a0www.CovidCollaborative.us<\/a>, and follow the COVID Collaborative on\u00a0Twitter<\/a>\u00a0and\u00a0LinkedIn.<\/a><\/p>\n

\n About the CDL Rapid Screening Consortium
<\/b>The CDL Rapid Screening Consortium (CDL RSC) is a private-led, not-for-profit initiative formed in August 2020<\/span> with the goal of establishing a robust rapid screening system and operational implementation strategy to be delivered as a public good to Canada<\/span> and then the world. The Consortium is led by Creative Destruction Lab. This is an unprecedented collaboration among businesses, researchers, and government working together on a singular public-interest objective. Learn more about CDL RSC at\u00a0https:\/\/www.cdlrapidscreeningconsortium.com<\/a><\/p>\n

\n MEDIA CONTACT:<\/b>\n <\/p>\n

\n Michael Schneider<\/span>
\n
+1 (217) 260-5041\u00a0
michael.schneider@genpact.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/us-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing-301373458.html<\/a><\/p>\n

SOURCE Genpact<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Group focused on employees’ safe return to offices sees requirement as driving individual health and wellness and workplace safety PR Newswire NEW YORK, Sept. 10, 2021 \/PRNewswire\/ —\u00a0The U.S. Rapid Action Consortium commends U.S. President Joe Biden’s call for companies with more than 100 employees to require vaccinations or weekly tests to ensure individual health and workplace safety. The Consortium also supports expanding easy-to-use testing production and making at-home tests more affordable. The organization, which has been focused on reopening the U.S. economy quickly since its inception in March 2021, is helping companies accelerate the use of safe, cost-effective rapid COVID-19 testing to better enable businesses to return to the office safely. Built on the highly successful Canadian model, the … <\/p>\n

Continue reading “U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-537004","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nU.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Group focused on employees’ safe return to offices sees requirement as driving individual health and wellness and workplace safety PR Newswire NEW YORK, Sept. 10, 2021 \/PRNewswire\/ —\u00a0The U.S. Rapid Action Consortium commends U.S. President Joe Biden’s call for companies with more than 100 employees to require vaccinations or weekly tests to ensure individual health and workplace safety. The Consortium also supports expanding easy-to-use testing production and making at-home tests more affordable. The organization, which has been focused on reopening the U.S. economy quickly since its inception in March 2021, is helping companies accelerate the use of safe, cost-effective rapid COVID-19 testing to better enable businesses to return to the office safely. Built on the highly successful Canadian model, the … Continue reading "U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-10T16:03:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY02286&sd=2021-09-10\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing\",\"datePublished\":\"2021-09-10T16:03:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/\"},\"wordCount\":959,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY02286&sd=2021-09-10\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/\",\"name\":\"U.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY02286&sd=2021-09-10\",\"datePublished\":\"2021-09-10T16:03:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY02286&sd=2021-09-10\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY02286&sd=2021-09-10\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing - Market Newsdesk","og_description":"Group focused on employees’ safe return to offices sees requirement as driving individual health and wellness and workplace safety PR Newswire NEW YORK, Sept. 10, 2021 \/PRNewswire\/ —\u00a0The U.S. Rapid Action Consortium commends U.S. President Joe Biden’s call for companies with more than 100 employees to require vaccinations or weekly tests to ensure individual health and workplace safety. The Consortium also supports expanding easy-to-use testing production and making at-home tests more affordable. The organization, which has been focused on reopening the U.S. economy quickly since its inception in March 2021, is helping companies accelerate the use of safe, cost-effective rapid COVID-19 testing to better enable businesses to return to the office safely. Built on the highly successful Canadian model, the … Continue reading \"U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-10T16:03:17+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY02286&sd=2021-09-10","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing","datePublished":"2021-09-10T16:03:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/"},"wordCount":959,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY02286&sd=2021-09-10","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/","name":"U.S. Rapid Action Consortium Commends President Biden's Call for Vaccines, Testing - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY02286&sd=2021-09-10","datePublished":"2021-09-10T16:03:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY02286&sd=2021-09-10","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY02286&sd=2021-09-10"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/u-s-rapid-action-consortium-commends-president-bidens-call-for-vaccines-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"U.S. Rapid Action Consortium Commends President Biden’s Call for Vaccines, Testing"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/537004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=537004"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/537004\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=537004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=537004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=537004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}